Clinical and neurobiological correlates of tardive dyskinesia in schizophrenia spectrum disorders and mood disorders
Open Access
- 24 August 2026
- journal article
- research article
- Published by Springer Nature in Schizophrenia
- Vol. 12 (1) , 69
Abstract
Tardive dyskinesia (TD) is a persistent sensorimotor syndrome associated with antipsychotic exposure in schizophrenia spectrum disorders (SSD) and mood disorders (MOD), yet its neurobiological basis remains poorly understood. We investigated whether TD represents a distinct clinical and neurobiological phenotype across SSD and MOD. In this study, we examined a bicentric cohort of 453 individuals with SSD ( n = 360) or MOD ( n = 93), including early-psychosis (EP) and multiple-episode SSD patients. TD status was defined using Schooler and Kane criteria based on the Abnormal Involuntary Movement Scale (AIMS). Psychopathology was assessed with the Positive and Negative Syndrome Scale (PANSS). Structural MRI data were processed using FreeSurfer (v7.4.1). Propensity score matching was applied to compare TD-positive and TD-negative patients while controlling for age, sex, illness duration, antipsychotic dose, and PANSS scores. TD prevalence was 10.6% in multiple-episode SSD ( n = 31) and 7.5% in MOD ( n = 7), whereas no EP patients met criteria for TD. Logistic regression identified male sex ( p = 0.005) and higher PANSS general psychopathology scores ( p = 0.021) as independent predictors of TD. TD-positive patients showed reduced paracentral cortical surface area in both the matched SSD sample ( n = 86; p = 0.006, corr.) and the combined transdiagnostic sample ( n = 179; p = 0.024, corr.). These alterations were absent in EP patients. In conclusion, our findings suggest that TD is a transdiagnostic phenomenon, occurring in both SSD and MOD. However, TD in SSD appears to be associated with a distinct clinical and neurobiological phenotype, marked by greater illness severity, male predominance, and focal sensorimotor cortical alterations.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (HI 1928/5-1)
- Deutsche Forschungsgemeinschaft (HI 1928/6-1)
- Deutsche Forschungsgemeinschaft (HI 1928/14-1)
This publication has 104 references indexed in Scilit:
- The Impact of Antipsychotic Dose Reduction on Clinical Outcomes and Health Care Resource Use Among Medicare Patients with SchizophreniaClinical Drug Investigation, 2021
- Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophreniaQuality of Life Research, 2019
- Patterns of co‐altered brain structure and function underlying neurological soft signs in schizophrenia spectrum disordersHuman Brain Mapping, 2019
- Tardive dyskinesia risk with first‐ and second‐generation antipsychotics in comparative randomized controlled trials: a meta‐analysisWorld Psychiatry, 2018
- Longitudinal Progression of Movement Abnormalities in Relation to Psychotic Symptoms in Adolescents at High Risk of SchizophreniaArchives of General Psychiatry, 2008
- Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatmentEuropean Child & Adolescent Psychiatry, 2006
- Structural Brain Differences Between Never-Treated Patients With Schizophrenia, With and Without Dyskinesia, and Normal Control SubjectsArchives of General Psychiatry, 2002
- Tardive Dyskinesia: Prevalence, Incidence, and Risk Factors1985
- Spontaneous Involuntary Disorders of MovementArchives of General Psychiatry, 1982
- Research Diagnoses for Tardive DyskinesiaArchives of General Psychiatry, 1982